[go: up one dir, main page]

ATA285187A - Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel - Google Patents

Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel

Info

Publication number
ATA285187A
ATA285187A AT2851/87A AT285187A ATA285187A AT A285187 A ATA285187 A AT A285187A AT 2851/87 A AT2851/87 A AT 2851/87A AT 285187 A AT285187 A AT 285187A AT A285187 A ATA285187 A AT A285187A
Authority
AT
Austria
Prior art keywords
production
amino acids
products containing
alpha amino
medicinal products
Prior art date
Application number
AT2851/87A
Other languages
English (en)
Other versions
AT393384B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA285187A publication Critical patent/ATA285187A/de
Application granted granted Critical
Publication of AT393384B publication Critical patent/AT393384B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3882Arylalkanephosphonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT2851/87A 1986-10-30 1987-10-29 Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel AT393384B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868625941A GB8625941D0 (en) 1986-10-30 1986-10-30 Substituted alpha-amino acids

Publications (2)

Publication Number Publication Date
ATA285187A true ATA285187A (de) 1991-03-15
AT393384B AT393384B (de) 1991-10-10

Family

ID=10606531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT2851/87A AT393384B (de) 1986-10-30 1987-10-29 Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel

Country Status (27)

Country Link
US (1) US5162311A (de)
JP (2) JPH0641475B2 (de)
KR (1) KR950004960B1 (de)
AT (1) AT393384B (de)
AU (1) AU614726B2 (de)
BE (1) BE1002421A4 (de)
CA (1) CA1310331C (de)
CH (1) CH677794A5 (de)
CY (1) CY1703A (de)
DE (1) DE3736016C2 (de)
DK (1) DK565987A (de)
ES (1) ES2012521A6 (de)
FI (1) FI87222C (de)
FR (1) FR2606018B1 (de)
GB (2) GB8625941D0 (de)
GR (1) GR871659B (de)
HK (1) HK110393A (de)
HU (1) HU200465B (de)
IE (1) IE59310B1 (de)
IL (1) IL84302A (de)
IT (1) IT1212033B (de)
LU (1) LU87031A1 (de)
NL (1) NL8702485A (de)
NZ (1) NZ222333A (de)
PT (1) PT86018B (de)
SE (1) SE466311B (de)
ZA (1) ZA878176B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395827A (en) * 1986-04-09 1995-03-07 Guilford Pharmaceuticals Inc. ω-[2-(phosphonoalkyl)phenyl]-2-aminoalkanoic acids as antagonists of excitatory amino acid receptors
US4918064A (en) * 1987-10-21 1990-04-17 G. D. Searle & Co. Phenyl glycines for use in reducing neurotoxic injury
US5175153A (en) * 1987-11-30 1992-12-29 Warner-Lambert Company Substituted alpha-amino acids having pharmaceutical activity
FR2634763B1 (fr) * 1988-08-01 1991-07-12 Inst Nat Sante Rech Med Amino-acides et peptides presentant un residu tyrosine modifiee, leur preparation et leur application comme medicaments
US4997821A (en) * 1988-10-21 1991-03-05 Cordi Alexis A Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury
US5177240A (en) * 1988-10-21 1993-01-05 G. D. Searle & Co. O-phosphono(alkyl)-n-sulfonyl-phenyl-alanine derivatives useful as intermediates for preparation of phosphono-hydroisoquinolines
US5100654A (en) * 1989-04-07 1992-03-31 Yale University Phosphorylated derivatives of l-dopa and compositions and methods for increasing the melanin content in mammalian skin and hair
DE3940410A1 (de) * 1989-12-04 1991-06-06 Schering Ag Neue verwendung von nmda-rezeptor-antagonisten
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
US5475129A (en) * 1991-09-30 1995-12-12 The United States Of America As Represented By The Department Of Health And Human Services Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis
US5264607A (en) * 1991-09-30 1993-11-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Process of making benzylic α,α-diflurophosphonates from benzylic α-ketophosphorates
US5200546A (en) * 1991-09-30 1993-04-06 The United States Of America As Represented By The Department Of Health And Human Services Phosphonoalkyl phenylalanine compounds suitably protected for use in peptide synthesis
GB9325360D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
US5489717A (en) * 1994-07-08 1996-02-06 Warner-Lambert Company Glutamate (NMDA) receptor antagonists
GB9423019D0 (en) * 1994-11-15 1995-01-04 Sandoz Ltd Improvements in or relating to organic compounds
US5922697A (en) * 1996-10-02 1999-07-13 Warner-Lambert Company Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins
US6133281A (en) * 1996-10-24 2000-10-17 Harbor-Ucla Research And Education Institute NMDA receptor blockers in the therapy of urogenital disease
EP1009407B1 (de) * 1997-09-04 2004-04-28 Novoneuron, Inc. Noribogain zur behandlung von schmerzen und drogenabhängigkeit
MY153569A (en) * 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
MY140707A (en) * 2002-02-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Process for preparing a phenylalanine derivative and intermediates thereof
DE10328260A1 (de) * 2003-06-23 2005-01-27 Schmidt, K.-G., Dr. med. Flupirtine-Präparat
EP1754483A1 (de) * 2005-08-18 2007-02-21 Merck Sante Verwendung von Thienopyridonederivativen als AMPK Aktivatoren und pharmazeutische Zusammensetzungen, die diese enthalten
JP2013534914A (ja) 2010-06-09 2013-09-09 クイーン マリー アンド ウエストフィールド カレッジ、ユニバーシティ オブ ロンドン アネキシン1抗体
GB201121564D0 (en) * 2011-12-14 2012-01-25 Queen Mary & Westfield College Use of antibody
GB201702091D0 (en) 2017-02-08 2017-03-22 Medannex Ltd Specific binding molecules
EP3427729A1 (de) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid zur behandlung von epileptischen erkrankungen, störungen oder zuständen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550634A (de) * 1955-08-30
BE626546A (de) * 1961-12-30
DE2459491A1 (de) * 1974-12-17 1976-06-24 Bayer Ag Gegenueber isocyanaten reaktive phosphorhaltige flammschutzmittel
US4657899A (en) * 1986-04-09 1987-04-14 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors
US4761405A (en) * 1987-03-04 1988-08-02 Nova Pharmaceutical Corporation Antagonists of specific excitatory amino acid neurotransmitter receptors having increased potency
US4918064A (en) * 1987-10-21 1990-04-17 G. D. Searle & Co. Phenyl glycines for use in reducing neurotoxic injury

Also Published As

Publication number Publication date
CH677794A5 (de) 1991-06-28
PT86018A (en) 1987-11-01
AU614726B2 (en) 1991-09-12
CA1310331C (en) 1992-11-17
FR2606018B1 (fr) 1990-11-16
JPH0641475B2 (ja) 1994-06-01
ZA878176B (en) 1989-06-28
GB2198134A (en) 1988-06-08
US5162311A (en) 1992-11-10
JPS63122693A (ja) 1988-05-26
NZ222333A (en) 1990-09-26
FI874761A0 (fi) 1987-10-29
DK565987D0 (da) 1987-10-28
FI87222C (fi) 1992-12-10
DE3736016A1 (de) 1988-05-05
JPH03101685A (ja) 1991-04-26
KR950004960B1 (ko) 1995-05-16
BE1002421A4 (fr) 1991-02-05
FR2606018A1 (fr) 1988-05-06
FI874761A (fi) 1988-05-01
IL84302A0 (en) 1988-03-31
GB8724186D0 (en) 1987-11-18
KR890006661A (ko) 1989-06-15
IT8748544A0 (it) 1987-10-28
GR871659B (en) 1988-03-03
DK565987A (da) 1988-05-01
FI87222B (fi) 1992-08-31
GB2198134B (en) 1990-07-04
DE3736016C2 (de) 1995-04-20
IT1212033B (it) 1989-11-08
PT86018B (pt) 1990-07-31
ES2012521A6 (es) 1990-04-01
AT393384B (de) 1991-10-10
IE59310B1 (en) 1994-02-09
SE8704204L (sv) 1988-05-01
AU8040487A (en) 1988-05-05
NL8702485A (nl) 1988-05-16
HUT47949A (en) 1989-04-28
LU87031A1 (fr) 1988-05-03
CY1703A (en) 1994-01-14
GB8625941D0 (en) 1986-12-03
SE8704204D0 (sv) 1987-10-28
IL84302A (en) 1993-06-10
IE872908L (en) 1988-04-30
HU200465B (en) 1990-06-28
SE466311B (sv) 1992-01-27
HK110393A (en) 1993-10-29

Similar Documents

Publication Publication Date Title
ATA285187A (de) Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel
DE3751845D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung
DE3780329D1 (de) Chinoloncarbonsaeure-derivate und ihre herstellung.
ATE124951T1 (de) Fluorcytidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten.
DE3782751D1 (de) Hydroxylaminderivate, deren herstellung und verwendung fuer heilmittel.
DE3780223D1 (de) Arzneimittel mit gesteuerter freisetzung.
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
AT388913B (de) Neue n-(2'-aminophenyl)-benzamid-derivate und arzneimittel, die diese enthalten
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE3771146D1 (de) Pyrimidinderivate, ihre herstellung und medikamente, die diese derivate enthalten.
DE3670639D1 (de) Neue biphosphonische abkoemmlinge, deren herstellung und arzneimittelzubereitung.
DE3685604D1 (de) 1,7-naphthyridinderivate und diese enthaltende arzneimittel.
ATE40826T1 (de) 4'-demethyl-4-epipodophyllotoxinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3876913D1 (de) Herstellung von kohlenstoffhaltigen pulvern und ihre granulierung.
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
DE3782112D1 (de) Pyrimidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten.
DK103987A (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
ATA36788A (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE59002899D1 (de) Aromatische carbonsaeureamide, ihre herstellung und verwendung fuer heilmittel.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
DE3786927D1 (de) Antithrombotische arzneimittel und deren herstellung.
DE3676360D1 (de) Nitroderivate von vinblastintyp-bis-indolen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IT1211681B (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
DE3761379D1 (de) 1,3-propandiaminderivate, ihre herstellung und sie enthaltende arzneimittel.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee